by Jordana Choucair | May 10, 2022 | M&A
Pfizer Inc. said it will spend about $11.6 billion to buy the rest of Biohaven Pharmaceutical Holding Co., which makes the prescription migraine drug Nurtec. The deal, which is expected to be completed by early 2023, will give Pfizer full ownership of Biohaven after...
by Jordana Choucair | May 10, 2022 | Mental Health
Senators Chris Murphy and Bill Cassidy introduced bipartisan legislation to reauthorize a series of mental health and substance use disorder programs expected to expire later this year. The Mental Health Reform Reauthorization Act of 2022 would offer a major boost in...
by Jordana Choucair | May 10, 2022 | Mental Health
Last month, the New York Times began publishing a series examining adolescent mental health and the culprits that have led to its decline. While the COVID-19 pandemic has undeniably played a role, adolescent mental health has been trending downward over the last three...
by Jordana Choucair | May 10, 2022 | Opioid/Substance Use Disorders
A federal judge in Cleveland will begin hearing testimony today to determine how much three pharmacy chains should pay two Ohio counties in damages to help abate the effects of the opioid crisis. Last fall, a jury found that the way CVS, Walgreens, and Walmart...
by Jordana Choucair | May 10, 2022 | Providers
The Leapfrog Group released its twice-annual hospital safety grades and an accompanying inpatient experience report showing a general decline among several hospital safety measures concurrent with the onset of the COVID-19 pandemic. Of the 3,000 U.S. general hospitals...
Recent Comments